Vesicare and Colon cancer metastatic - a phase IV clinical study of FDA data

Summary:

Colon cancer metastatic is reported only by a few people who take Vesicare.

The phase IV clinical study analyzes which people take Vesicare and have Colon cancer metastatic. It is created by eHealthMe based on reports of 28,723 people who have side effects while taking Vesicare from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 28, 2023

28,723 people reported to have side effects when taking Vesicare.
Among them, 2 people (0.01%) have Colon cancer metastatic.

What is Vesicare?

Vesicare has active ingredients of solifenacin succinate. It is often used in urge incontinence. eHealthMe is studying from 29,496 Vesicare users for its effectiveness, alternative drugs and more.

What is Colon cancer metastatic?

Colon cancer metastatic (cancer of colon spreads to other part of body) is found to be associated with 602 drugs and 319 conditions by eHealthMe.

Number of Vesicare and Colon cancer metastatic reports submitted per year:

Could Vesicare cause Colon cancer metastatic?

Gender of people who have Colon cancer metastatic when taking Vesicare *:

female: 0.0 %
male: 100 %

Common drugs people take besides Vesicare *:

Common side effects people have besides Colon cancer metastatic *:

Death: 2 people, 100.00%

Common conditions people have *:

Prostate Cancer: 2 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Vesicare and have Colon cancer metastatic?

Check whether Colon cancer metastatic is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Colon cancer metastatic and when was it recovered:

Colon cancer metastatic in Vesicare

Expand to all the drugs that have ingredients of solifenacin succinate:

Colon cancer metastatic and drugs with ingredients of solifenacin succinate

Alternative drugs to, pros and cons of Vesicare:

Vesicare (29,496 reports)

Common Vesicare side effects:

Drug ineffective: 4,111 reports
Constipation: 1,854 reports
Fatigue (feeling of tiredness): 1,609 reports
Dizziness: 1,265 reports
Urinary tract infection: 1,160 reports
Weakness: 1,122 reports

Browse all side effects of Vesicare:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Colon cancer metastatic treatments and more:

Colon cancer metastatic (7,891 reports)

COVID vaccines that are related to Colon cancer metastatic:

Common drugs associated with Colon cancer metastatic:

Avastin: 140 reports
Fluorouracil: 130 reports
Oxaliplatin: 126 reports
Humira: 114 reports

How the study uses the data?

The study uses data from the FDA. It is based on solifenacin succinate (the active ingredients of Vesicare) and Vesicare (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.